Arnold P. Oranje
Research Subjects
Research Interests
Arnold P. Oranje has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Sherief Rahit Janmohamed
Universitair Ziekenhuis Brussel
15 shared publications Flora B. de Waard-Van der Spek
Franciscus Gasthuis and Vlietland
4 shared publicationsG. C. Madern
Department of Paediatric Surgery, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
4 shared publicationsG.C. Madern
Afdeling Kinderchirurgie, Erasmus MC-Sophia Kinderziekenhuis, Rotterdam, The Netherlands
4 shared publicationsP.C.J. de Laat
Afdeling Kindergeneeskunde, Erasmus MC-Sophia Kinderziekenhuis, Rotterdam, The Netherlands
4 shared publicationsGerard C. Madern
Erasmus MC
3 shared publications
Latest Publications
- 22 July 2016
- Published by Springer Nature
- p. 79-89
Multiple Cutaneous Infantile Hemangioma and the Risk of Internal Hemangioma
- 22 July 2016
- Published by Springer Nature
- p. 79-89
Multiple Cutaneous Infantile Hemangioma and the Risk of Internal Hemangioma
- 22 July 2016
- Published by Springer Nature
- p. 69-78
Controversies in the Treatment of Infantile Haemangiomas with β-Blockers
- 22 July 2016
- Published by Springer Nature
- p. 69-78
Controversies in the Treatment of Infantile Haemangiomas with β-Blockers
- 22 July 2016
- Published by Springer Nature
- p. 11-16
Proactive Therapy in Atopic Dermatitis
- 22 July 2016
- Published by Springer Nature
- p. 259-262
Photography in Pediatric Dermatology: More Important than Many Physicians Think
- 22 July 2016
- Published by Springer Nature
- p. 259-262
Photography in Pediatric Dermatology: More Important than Many Physicians Think
- 22 July 2016
- Published by Springer Nature
- p. 3-8
Pediatrics, “Dermatopediatrics”, and Pediatric Dermatology
- 22 July 2016
- Published by Springer Nature
- p. 3-8
Pediatrics, “Dermatopediatrics”, and Pediatric Dermatology
- 1 June 2015
- Published by Elsevier in Journal of Infection
- Vol. 71, S76-S79
Recent developments in the management of common childhood skin infections
- 1 June 2015
- Published by Elsevier in Journal of Infection
- Vol. 71, S76-S79
Recent developments in the management of common childhood skin infections
- 31 January 2015
- Published by S. Karger AG in Dermatology
- Vol. 230 (2) , 105-112
Correlation between Objective SCORAD and Three-Item Severity Score Used by Physicians and Objective PO-SCORAD Used by Parents/Patients in Children with Atopic Dermatitis
Background: A self-assessment rating scale (SAS) is a good tool to assess the fluctuating disease severity and quality of life (QoL) in children with atopic dermatitis (AD). The European Task Force on Atopic Dermatitis created an SAS based on the Scoring Atopic Dermatitis (SCORAD) index, called the Patient-Oriented SCORAD (PO-SCORAD). Objective: The aim of our study was to measure the correlation between alternative systems such as the Objective SCORAD, the Three-Item Severity (TIS) score and the Objective PO-SCORAD. We also investigated the correlations between the objective severity assessments and QoL. Methods: In a specialized outpatient clinic, an observational prospective study was performed with children ≤16 years with AD. Results: Seventy-five children were included. A good and significant correlation was shown between Objective SCORAD and Objective PO-SCORAD: Spearman's ρ correlation (rs) = 0.63 (p < 0.001). The correlation with QoL was moderate, but still significant (rs = 0.41-0.61, p < 0.001). Conclusion: The Objective PO-SCORAD can be used for the evaluation of fluctuating AD and correlates significantly with the Objective SCORAD and the less time-consuming TIS score.
- 31 January 2015
- Published by S. Karger AG in Dermatology
- Vol. 230 (2) , 105-112
Correlation between Objective SCORAD and Three-Item Severity Score Used by Physicians and Objective PO-SCORAD Used by Parents/Patients in Children with Atopic Dermatitis
Background: A self-assessment rating scale (SAS) is a good tool to assess the fluctuating disease severity and quality of life (QoL) in children with atopic dermatitis (AD). The European Task Force on Atopic Dermatitis created an SAS based on the Scoring Atopic Dermatitis (SCORAD) index, called the Patient-Oriented SCORAD (PO-SCORAD). Objective: The aim of our study was to measure the correlation between alternative systems such as the Objective SCORAD, the Three-Item Severity (TIS) score and the Objective PO-SCORAD. We also investigated the correlations between the objective severity assessments and QoL. Methods: In a specialized outpatient clinic, an observational prospective study was performed with children ≤16 years with AD. Results: Seventy-five children were included. A good and significant correlation was shown between Objective SCORAD and Objective PO-SCORAD: Spearman's ρ correlation (rs) = 0.63 (p < 0.001). The correlation with QoL was moderate, but still significant (rs = 0.41-0.61, p < 0.001). Conclusion: The Objective PO-SCORAD can be used for the evaluation of fluctuating AD and correlates significantly with the Objective SCORAD and the less time-consuming TIS score.
- 16 December 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (4) , 431-437
Support for the hypoxia theory in the pathogenesis of infantile haemangioma
The pathogenesis of infantile haemangioma (IH) is unknown. Several mechanisms have been proposed, including hypoxia, which triggers upregulation and stabilization of hypoxia-inducible factor (HIF)1α. HIF1α stimulates downstream transcription of target genes that enhance angiogenesis.To identify possible involvement of hypoxia in the pathogenesis of IH, as hypoxia signalling constitutes a potential therapeutic target.IH tissue samples collected during the period 1991-2011 (preserved in paraffin wax) were immunohistochemically analysed for HIF1α and the known HIF1α targets: BCL2/adenovirus E1B kD-interacting protein family member 3 (BNIP3), carbon anhydrase (CA)-IX, glucose transporter (GLUT)-1, phosphorylated protein kinase B (pAKT), phosphorylated S6 protein (pS6) and vascular endothelial growth factor (VEGF). Four observers independently assessed the findings.Of the 10 IH samples, 2 appeared to be in the growth phase. In all samples, GLUT-1, BNIP3, pAKT and VEGF were positive, CA-IX was weakly positive, and HIF1α was negative. pS6 was positive in 9/10 cases and negative in 1/10.Several factors implicated in hypoxia-induced angiogenesis may be involved in IH development. However, the small sample size and retrospective approach of the study preclude definitive conclusions. Prospective studies are needed to conclusively determine which of the factors involved in the (hypoxia) cascade are required for an IH to grow, and could thus be a possible target of drugs for IH treatment.
- 16 December 2014
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (4) , 431-437
Support for the hypoxia theory in the pathogenesis of infantile haemangioma
The pathogenesis of infantile haemangioma (IH) is unknown. Several mechanisms have been proposed, including hypoxia, which triggers upregulation and stabilization of hypoxia-inducible factor (HIF)1α. HIF1α stimulates downstream transcription of target genes that enhance angiogenesis.To identify possible involvement of hypoxia in the pathogenesis of IH, as hypoxia signalling constitutes a potential therapeutic target.IH tissue samples collected during the period 1991-2011 (preserved in paraffin wax) were immunohistochemically analysed for HIF1α and the known HIF1α targets: BCL2/adenovirus E1B kD-interacting protein family member 3 (BNIP3), carbon anhydrase (CA)-IX, glucose transporter (GLUT)-1, phosphorylated protein kinase B (pAKT), phosphorylated S6 protein (pS6) and vascular endothelial growth factor (VEGF). Four observers independently assessed the findings.Of the 10 IH samples, 2 appeared to be in the growth phase. In all samples, GLUT-1, BNIP3, pAKT and VEGF were positive, CA-IX was weakly positive, and HIF1α was negative. pS6 was positive in 9/10 cases and negative in 1/10.Several factors implicated in hypoxia-induced angiogenesis may be involved in IH development. However, the small sample size and retrospective approach of the study preclude definitive conclusions. Prospective studies are needed to conclusively determine which of the factors involved in the (hypoxia) cascade are required for an IH to grow, and could thus be a possible target of drugs for IH treatment.